Skip to content

Study · Not a test of the peptide alone · 2007

3 results

Ghrelin and the enteroinsular axis in healthy men.

Micic D, Duntas L, Cvijovic G, Kendereski A, Sumarac-Dumanovic M, Jehle P, Zoric S, Pejkovic D, Lague M, Dieguez C, Casanueva F

Hormones (Athens, Greece)1 Oct 2007Cited by 1 (Europe PMC)

PMID18055423 (opens in a new tab)DOI10.14310/horm.2002.1111028 (opens in a new tab)PepBankPUB-18055423
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01HumanNot a test of GHRP-6 aloneNon-randomized trialActivity measurement

    In healthy men, the abstract describes an increase in glucose AUC after ghrelin in Test 1 compared to Test 3, but which test was higher is unclear.

    In plain wordsIn healthy men, blood sugar response to ghrelin differed between the saline and GHRP‑6 days, but the abstract does not clearly state which was higher.

    Peptide
    GHRP-6
    Outcome
    Direction not reportedGlucose AUC after ghrelin
    Study

    n = 6

    Comparator
    Saline followed by ghrelin (Test 1)
    Outcome group
    Glycemic control · Metabolic and weight

    Measurements

    Glucose AUC
    526.41 mmol . ml(-1) . min
    first value in the abstract's Test 1 versus Test 3 comparison; order not explicit
    Glucose AUC
    566.37 mmol . ml(-1) . min
    second value in the abstract's Test 1 versus Test 3 comparison; order not explicit

    Source sentences

    Summary
    There was a significant increase in AUC glucose (526.41+/-22.91 mmol . ml(-1) . min vs. 566.37+/-15.64 mmol . ml(-1) . min; p<0.05)
    2 context sentences
    Summary · context
    after ghrelin administration in Test 1 compared to Test 3.
    Summary · context
    on the third experimental day, GHRP-6 was administered at 0 min, followed by a ghrelin bolus at 120 min (Test 3).

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  2. 02HumanNot a test of GHRP-6 aloneNon-randomized trialActivity measurement

    In healthy men, insulin AUC after ghrelin differed significantly between Test 1 (saline first) and Test 3 (GHRP‑6 first), 756.25 vs 981.62 mU . ml(-1) . min; the abstract's direction wording is unclear.

    In plain wordsIn healthy men, insulin AUC differed significantly between the saline test and the GHRP‑6 test; the abstract's direction wording is unclear.

    Peptide
    GHRP-6
    Outcome
    Direction not reportedInsulin AUC after ghrelin
    Study

    n = 6

    Comparator
    Saline followed by ghrelin (Test 1)
    Outcome group
    Glycemic control · Metabolic and weight

    Measurements

    AUC insulin
    756.25 mU . ml(-1) . min
    First value reported in the Test 1 vs Test 3 comparison
    AUC insulin
    981.62 mU . ml(-1) . min
    Second value reported in the Test 1 vs Test 3 comparison

    Source sentences

    Summary
    and AUC insulin (756.25+/-107.56 mU . ml(-1) . min vs. 981.62+/-180.32 mU . ml(-1) . min; p<0.05)
    2 context sentences
    Summary · context
    after ghrelin administration in Test 1 compared to Test 3.
    Summary · context
    on the third experimental day, GHRP-6 was administered at 0 min, followed by a ghrelin bolus at 120 min (Test 3).

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  3. 03HumanNot a test of GHRP-6 aloneNon-randomized trialActivity measurement

    In healthy men, GLP-1 AUC after ghrelin differed significantly between Test 1 (saline first) and Test 3 (GHRP‑6 first), 2346.87 vs 1769.5 pmol . ml(-1) . min; the abstract's direction wording is unclear.

    In plain wordsIn healthy men, GLP-1 AUC differed significantly between the saline test and the GHRP‑6 test; the abstract's direction wording is unclear.

    Peptide
    GHRP-6
    Outcome
    Direction not reportedGLP-1 AUC after ghrelin
    Study

    n = 6

    Comparator
    Saline followed by ghrelin (Test 1)
    Outcome group
    Glycemic control · Metabolic and weight

    Measurements

    AUC GLP-1
    2346.87 pmol . ml(-1) . min
    First value reported in the Test 1 vs Test 3 comparison
    AUC GLP-1
    1769.5 pmol . ml(-1) . min
    Second value reported in the Test 1 vs Test 3 comparison

    Source sentences

    Summary
    and a significant decrease in AUC GLP-1 (2346.87+/-874.28 pmol . ml(-1) . min vs. 1769.5+/-784 pmol . ml(-1) . min; p<0.05)
    2 context sentences
    Summary · context
    after ghrelin administration in Test 1 compared to Test 3.
    Summary · context
    on the third experimental day, GHRP-6 was administered at 0 min, followed by a ghrelin bolus at 120 min (Test 3).

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.